Structural insights into IKKβ inhibition by natural products staurosporine and quercetin

被引:12
作者
Avila, Carolina M. [1 ,2 ]
Romeiro, Nelilma C. [1 ,4 ]
Sant'Anna, Carlos M. R. [1 ,3 ]
Barreiro, Eliezer J. [1 ,2 ]
Fraga, Carlos A. M. [1 ,2 ]
机构
[1] Univ Fed Rio de Janeiro, LASSBio, Fac Farm, BR-21941902 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil
[3] Univ Fed Rural Rio de Janeiro, Dept Quim, ICE, BR-23851970 Seropedica, RJ, Brazil
[4] Univ Fed Rio de Janeiro, BR-27930560 Rio De Janeiro, Brazil
关键词
Staurosporine; Quercetin; IKKbeta; Serine threonine kinases; ATP binding-site inhibitors; Homology modeling; Molecular docking; Antiinflammatory drugs; NF-KAPPA-B; CRYSTAL-STRUCTURE; KINASE-BETA; ALPHA; ACTIVATION; COMPLEX; POTENT; MODEL; SHOW;
D O I
10.1016/j.bmcl.2009.10.076
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
This Letter describes the results of two combined approaches: homology modeling and molecular docking studies, in order to propose the molecular basis of IKK beta inhibition by staurosporine and quercetin as ATP-competitive inhibitors. The results provides a rationale and structural frameworks for designing potent ATP binding-site inhibitors of IKK beta, which is an attractive drug target for inflammatory diseases and has been found to be responsible for some of the already observed pharmacological effects for marketed drugs. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6907 / 6910
页数:4
相关论文
共 30 条
[1]
BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[2]
[Anonymous], 1996, Biomolecular Simulation: the GROMOS96 Manual and User Guide
[3]
BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009 [J].
Chang, Antje ;
Scheer, Maurice ;
Grote, Andreas ;
Schomburg, Ida ;
Schomburg, Dietmar .
NUCLEIC ACIDS RESEARCH, 2009, 37 :D588-D592
[4]
The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-α and IKK-β kinases [J].
Christopher, John A. ;
Avitabile, Barbara G. ;
Bamborough, Paul ;
Champigny, Aurelie C. ;
Cutler, Geoffrey J. ;
Dyos, Susan L. ;
Grace, Ken G. ;
Kerns, Jeffrey K. ;
Kitson, Jeremy D. ;
Mellor, Geoffrey W. ;
Morey, James V. ;
Morse, Mary A. ;
O'Malley, Carolyn F. ;
Patel, Champa B. ;
Probst, Nicholas ;
Rumsey, William ;
Smith, Clive A. ;
Wilson, Michael J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :3972-3977
[5]
DeMedina FS, 1996, J PHARMACOL EXP THER, V278, P771
[6]
SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[7]
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase [J].
Holder, Sheldon ;
Zemskova, Marina ;
Zhang, Chao ;
Tabrizizad, Maryam ;
Bremer, Ryan ;
Neidigh, Jonathan W. ;
Lilly, Michael B. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :163-172
[8]
IKKα controls formation of the epidermis independently of NF-κB [J].
Hu, YL ;
Baud, V ;
Oga, T ;
Kim, KII ;
Yoshida, K ;
Karin, M .
NATURE, 2001, 410 (6829) :710-714
[9]
Protein tyrosine kinases: autoregulation and small-molecule inhibition [J].
Hubbard, SR .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (06) :735-741
[10]
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog [J].
Hubbard, SR .
EMBO JOURNAL, 1997, 16 (18) :5572-5581